ARTG 475365saypha volume - Dermal tissue reconstructive material, microbe-derived
ARTG ID: 475365 · AA-Med Pty Ltd · Croma-Pharma GmbH · Class III · Started January 08, 2025
Good Name: AA-Med Pty Ltd - saypha volume - Dermal tissue reconstructive material, microbe-derived
- Risk Class
- Class III
- Product Type
- Procedure Pack
- ARTG Category
- General
- ARTG ID
- 475365
- Start Date
- January 08, 2025
- Effective Date
- January 08, 2025
- Name
- AA-Med Pty Ltd
- Country
- Austria
- Address
- Industriezeile 6, Leobendorf, 2100
The intended aesthetic purpose of saypha volume is to add volume. It is indicated to correct moderate to severe nasolabial folds, and must be injected into the deep dermis or subcutis.
Access comprehensive regulatory information for saypha volume - Dermal tissue reconstructive material, microbe-derived in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 475365 and sponsored by AA-Med Pty Ltd, manufactured by Croma-Pharma GmbH in Austria. The device registration started on January 08, 2025.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.